News

Visbiome® Probiotic Licensed for use in Irritable Bowel Syndrome (IBS) Posted on 27 Sep 11:00

ExeGi Pharma, LLC., announced today that Visbiome®, a high potency probiotic, has secured a licensed indication from Health Canada as a Natural Health Product for the relief of Irritable Bowel Syndrome (IBS) symptoms, including abdominal discomfort, gas, and bloating. IBS is a common gastrointestinal disorder which affects as many as 5 million Canadians.

Please Note

You are now leaving Visbiome.ca (Canada) for Visbiome US.

Proceed to Visbiome US Stay on the Canadian site